Dr Gisela Mautner


MD-PhD (TU-LMU Munich), MPH (Harvard), MBA (Kellogg), FACPE (Australia), AMCEOI, MAICD

Dr Mautner is an international business leader with significant experience developing and launching new pharmaceutical products and delivering successful corporate strategies in highly competitive global markets.

She is CEO and Managing Director of Noxopharm Ltd, a Non-Executive Director of Nyrada Inc, a US biotechnology company listed on the ASX and was appointed Director of Pharmorage Pty Ltd in 2022.

Gisela has been a successful professional in the medical sector for over 30 years, with leadership roles in global pharmaceutical organisation across multiple continents and therapeutic areas. She has a deep understanding of the industry gained in senior positions in major companies including MSD (Merck), Bayer and Amgen.

She has strong industry networks, having served the APPA (Australian Pharmaceutical Physicians Association) as President, Past-President, Vice-President and Treasurer for many years. Her international presence includes serving as Australian delegate to the International Federation of Associations of Pharmaceutical Physicians (IFAPP), which connects the pharmaceutical industry globally.

Dr Mautner holds a Doctor of Medicine degree and a PhD from Germany, a Master of Public Health (MPH) from Harvard University, and a Master of Business Administration (MBA) from Northwestern University of Chicago.